Mulberry Biotherapeutics

About:

Mulberry Biotherapeutics is developing novel targeted bacteria-mediated therapy for patients with NF2 and other non-cancerous neoplasms.

Website: https://www.mulberrybio.com

Description:

Mulberry Biotherapeutics is developing novel targeted bacteria-mediated therapy for patients with NF2 and other non-cancerous neoplasms. The company focused on delivering transformative improvements in the health and quality of life to individuals affected by the rare genetic disorder neurofibromatosis type 2 (NF2). Mulberry Biotherapeutics is based in Wellesley, MA.